Hatfield, Penn., Oct. 1, 2020 – CurveBeam announced The HiRise, its weight bearing CT imaging system for the entire lower extremity, has received CE marking.
CurveBeam is the leader in weight bearing CT imaging for the orthopedic extremities. Only CurveBeam systems offer a wide patient platform that lets patients stand naturally on both feet during a scan. CurveBeam’s HiRise can scan anywhere along the lower extremity from the hip & pelvis to the feet. Weight bearing CT imaging of the hip & pelvis is a novel application not previously available in any system.
"It is exciting to learn this innovative technology is now available in the United Kingdom and Europe,” said Dr. Sajid Butt, a consultant radiologist at Royal National Orthopedic Hospital-Stanmore.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
“Physiological assessment of the bones and joints has obvious advantages, but getting this data via multiplanar imaging enables accurate road maps for effective surgical planning. No other weight bearing imaging modality can provide as much information as the HiRise. The HiRise is competitively priced and is a robust and affordable resilience for any radiology department."
The HiRise gantry tilts for upper extremity imaging and supine lower leg imaging.
“At CurveBeam, we lead through innovation, driven by the clinical needs and research initiatives of our customers” said Director of European Affairs Guy Long. “In less than a decade after we introduced our first weight bearing CT system for foot & ankle, we are now launching our third-generation device which extends this groundbreaking technology to the hip.”
CurveBeam’s systems utilize cone beam CT technology and are designed for the orthopedic point-ofcare setting. The HiRise plugs into a standard wall outlet, requires minimal shielding, and is easy to operate.
CurveBeam anticipates FDA clearance for the HiRise in Q4 2020.